The Impact of Combined Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease on Long-Term Survival after Lung Cancer Surgery

Abstract

Purpose The purpose of this study was to determine the impact of pulmonary fibrosis (PF) on postoperative complications and on long-term survival after surgical resection in lung cancer patients with chronic obstructive pulmonary disease (COPD).

Patients and Methods A retrospective chart review was conducted of 380 patients with COPD who had undergone pulmonary resection for lung cancer at the University Hospital between 1990 and 2005. The definition of COPD was a preoperative forced expiratory volume in 1 second/forced vital capacity (FEV₁/FVC) ratio of less than 70%; PF was defined as obvious bilateral fibrous change in the lower lung fields, confirmed by computed tomography.

Results PF was present in 41 patients (10.8%) with COPD; the remaining 339 patients (89.2%) did not have PF. The preoperative FVC/FEV₁ was significantly lower in the group of patients with PF than in the group without (p < 0.05). Acute lung injury and home oxygen therapy were significantly more common in the PF group; however, the 30-day mortality was similar between the groups. The cumulative survival at 3 and 5 years was 53.6 and 36.9%, respectively, in the PF group and 71.4 and 66.1%, respectively, in the non-PF group (p = 0.0009). Increased age, decreased body mass index, advanced pathologic stage, and the existence of PF were identified as independent risk factors for decreased survival.

Conclusion PF is a risk factor for decreased survival after surgical treatment in lung cancer patients with COPD.

Keywords

lung cancer - chronic obstructive pulmonary disease - pulmonary fibrosis - combined pulmonary fibrosis and emphysema

Note

The Japanese version of this article was published in the official journal of the Japan Lung Cancer Society (Jpn J Lung Cancer 2013;53:7–11) and the permission for the second publication in English was given by this society.

• References

• 1 Hanley ME, King Jr TE, Schwarz MI, Watters LC, Shen AS, Cherniack RM. The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. Am Rev Respir Dis 1991; 144 (5) 1102-1106
• 2 Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007; 176 (3) 285-290
• 3 Wilson DO, Weissfeld JL, Balkan A , et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178 (7) 738-744
• 4 Cottin V, Nunes H, Brillet PY , et al; Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26 (4) 586-593
• 5 Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010; 15 (2) 265-271
• 6 Usui K, Tanai C, Tanaka Y, Noda H, Ishihara T. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 2011; 16 (2) 326-331
• 7 Sekine Y, Suzuki H, Yamada Y, Koh E, Yoshino I. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection. Thorac Cardiovasc Surg 2013; 61 (2) 124-130
• 8 Chiyo M, Sekine Y, Iwata T , et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 2003; 126 (4) 1141-1146
• 9 Rogliani P, Mura M, Mattia P , et al. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med 2008; 102 (12) 1753-1761
• 10 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152 (5, Pt 2): S77-S121
• 11 Mura M, Zompatori M, Pacilli AM, Fasano L, Schiavina M, Fabbri M. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care 2006; 51 (3) 257-265
• 12 Strickland NH, Hughes JM, Hart DA, Myers MJ, Lavender JP. Cause of regional ventilation-perfusion mismatching in patients with idiopathic pulmonary fibrosis: a combined CT and scintigraphic study. AJR Am J Roentgenol 1993; 161 (4) 719-725
• 13 Doherty MJ, Pearson MG, O'Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997; 52 (11) 998-1002
• 14 Mizuno S, Takiguchi Y, Fujikawa A , et al. Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology 2009; 14 (3) 377-383
• 15 Sakai F, Tominaga J, Kaga A , et al. Imaging diagnosis of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema). Pulm Med 2012; 2012: 816541
• 16 Saito H, Minamiya Y, Nanjo H , et al. Pathological finding of subclinical interstitial pneumonia as a predictor of postoperative acute respiratory distress syndrome after pulmonary resection. Eur J Cardiothorac Surg 2011; 39 (2) 190-194
• 17 Sekine Y, Suzuki H, Nakajima T, Yasufuku K, Yoshida S. Risk quantification for pulmonary complications after lung cancer surgery. Surg Today 2010; 40 (11) 1027-1033
• 18 Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 2012; 141 (1) 222-231
• 19 Congleton J, Muers MF. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med 1995; 89 (4) 291-296
• 20 Kurishima K, Satoh H, Ishikawa H , et al. Lung cancer patients with chronic obstructive pulmonary disease. Oncol Rep 2001; 8 (1) 63-65